Biodexa Pharmaceticals Stock Analysis

Biodexa Stock Analysis Notes

About 30.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.1. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biodexa Pharmaceticals recorded a loss per share of 77.5. The entity last dividend was issued on the 3rd of March 2020. The firm had 1:25 split on the 4th of October 2024. For more info on Biodexa Pharmaceticals please contact Stephen Stamp at 44 29 2048 0180 or go to https://www.biodexapharma.com.

Biodexa Pharmaceticals Investment Alerts

Biodexa Pharmaceticals Upcoming and Recent Events

Biodexa Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.17 M.

Biodexa Profitablity

Management Efficiency

Biodexa Pharmaceticals has return on total asset (ROA) of (0.3752) % which means that it has lost $0.3752 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9723) %, meaning that it created substantial loss on money invested by shareholders. Biodexa Pharmaceticals' management efficiency ratios could be used to measure how well Biodexa Pharmaceticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.12 in 2025. Return On Capital Employed is likely to rise to -1.76 in 2025. At this time, Biodexa Pharmaceticals' Other Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 1.3 M in 2025, whereas Total Assets are likely to drop slightly above 9 M in 2025.

Technical Drivers

As of the 25th of March, Biodexa Pharmaceticals shows the Standard Deviation of 7.59, risk adjusted performance of (0.11), and Mean Deviation of 5.01. Biodexa Pharmaceticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Biodexa Pharmaceticals Price Movement Analysis

Biodexa Pharmaceticals Predictive Daily Indicators

Biodexa Pharmaceticals Forecast Models

Biodexa Pharmaceticals' time-series forecasting models are one of many Biodexa Pharmaceticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biodexa Pharmaceticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biodexa Pharmaceticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biodexa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biodexa Pharmaceticals. By using and applying Biodexa Stock analysis, traders can create a robust methodology for identifying Biodexa entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biodexa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biodexa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Biodexa Pharmaceticals stock analysis indicators help investors evaluate how Biodexa Pharmaceticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biodexa Pharmaceticals shares will generate the highest return on investment. By understating and applying Biodexa Pharmaceticals stock analysis, traders can identify Biodexa Pharmaceticals position entry and exit signals to maximize returns.

When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.